SAN DIEGO, Dec. 22, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine ...
When I first started writing a book earlier this year about why millennial women have been uniquely screwed over by society’s body image ideals, I used the past tense a little too confidently. We’d ...
When people think of high-powered machines, they'd likely think of muscle cars before their own muscles. But muscles and other living tissues can do energetic things very quickly—they twitch, snap and ...
We mentioned last week that in iOS 26.1, Apple changed how the Clock app icon’s seconds hand moves in low power mode. Instead of continuously moving, the seconds hand ticks with each second like a ...
Xpeng (XPEV) shares surged about 6.2% on Tuesday during pre-market hours of trading on growing optimism about the company's progress in humanoid robot technology. The company highlighted that IRON is ...
Anthropic has been fighting to convince the Trump administration it isn’t “woke” – but that could be an uphill battle thanks to the AI giant’s ties to the bizarre, cult-like “Effective Altruism” ...
We've reached Week 10 of the 2025 NFL season, and this Tuesday featured the NFL trade deadline, which saw a ton of action, especially involving the New York Jets, who had a fire sale and acquired ...
As Dancing With The Stars continues to boogie its way through the 2025 TV schedule, a star of Season 34 showed us just how much work they put in throughout the course of a season. Dylan Efron's latest ...
Other peoples have risen. Other peoples have risen up to defend their rights, their dignity, and their democracies. In the past 50 years, they’ve done it in Poland, South Africa, Lebanon, South Korea, ...
A version of this story appeared in CNN Business’ Nightcap newsletter. To get it in your inbox, sign up for free here. The conversation was brief, but they talked about the phone the way you might ...
To anti-abortion activists who worked diligently to help President Trump win in 2024 and deliver a Republican trifecta, the Food and Drug Administration’s (FDA) decision last week to approve a generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback